27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

Cyanotech Corp.<br />

73-4460 Queen Kaahamanu Hwy., Suite 102<br />

Kailua-Kona HI 96740, US<br />

Phone: (808) 329-4677; Fax: (808) 329-4533<br />

Toll-free phone: (800) 453-1187<br />

Web: www.cyanotech.com<br />

E-mail: info@cyanotech.com<br />

KEY PERSONNEL: Gerald R. Cysewski; Chairman, President and CEO<br />

William R. Maris; VP, Finance and CFO<br />

Glenn Jenson; VP, Operations<br />

Robert J. Capelli; VP, Sales<br />

EMPLOYEES: 64 employees<br />

HISTORY: Founded in 1983 by Gerald Cysewski (5% equity interest, 6/96)<br />

Originally formed from merger of Altex Technology and White Mountain Inc.<br />

FACILITIES: Algae production facility on 90-acre site in Kailua-Kona, Hawaii<br />

STOCK-FINANCIAL HISTORY: NASDAQ--CYAN (Capital Market)<br />

Follow-on public offering--1.5M shares at $7/share, $11.445M (3/96)<br />

Net sales $11.131M (YE 06) compared to $8.951M (YE 05)<br />

Net loss (YE 06) compared to (YE 05)<br />

Loss per share (YE 06) compared to (YE 05)<br />

Average shares outstanding 20.904M (YE 06) compared to 20.784M (YE<br />

05)<br />

Total assets $17.473M (YE 06) compared to $18.542M (YE 05)<br />

PRIVATE PLACEMENTS: Spirulina Research Partners--RDLP for spirulina research--$635K (10/84)<br />

$150K, 600K shares (11/83)<br />

$276K, 920K shares (6/84)<br />

$250K, 625K preferred shares (6/85)<br />

$1.5M (7/86)<br />

$2.35M, 235K shares (1/94)<br />

$1.55M, convertible subordinated debentures and common stock (11/02)<br />

PRINCIPAL INVESTORS: Continental Corp.--$500K, 1.25M preferred shares (1985); 292,430 shares<br />

of common stock at $1/share (1986), $1.97M, 79shares of preferred stock<br />

(2/90)<br />

Cosmo Ventures--$1M, 750K shares (1985, 1986)<br />

BUSINESS STRATEGY: Develop high-value products from microalgae<br />

Establish retail marketing subsidiary<br />

AGREEMENTS: Name Products Content of Agreement Date<br />

Scripps Research Scripps' Aldolase licensing agreement 4/98<br />

Institute<br />

Catalytic Antibody 38C2<br />

in microalgae<br />

University of microalgae that is toxic licensing agreement 7/95<br />

Memphis<br />

to mosquito larvae<br />

RESEARCH & DEVELOPMENT: Algal drying technique permitting dormancy<br />

Pigments for cosmetics, fragrances, food coloring<br />

Astaxanthin for aquaculture feeds<br />

PRODUCTS ON MARKET: BioAstin® natural astaxanthin<br />

Phycobiliproteins as fluorescent dyes for labeling MAbs in cell sorters and<br />

assays<br />

Spirulina Pacifica® protein supplement as food supplement<br />

NatuRose® natural astaxanthin product<br />

Genetic engineering of microalgae to produce transgenic protein<br />

Copyright ©2006 AHC Media ® 127

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!